Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-28

Clinical Trial Update: Study of Asoprisnil in the Treatment of Uterine Fibroids. [Phase 3]

View source ↗

Summary

Abbott's Phase 3 study of Asoprisnil for uterine fibroids has completed. The trial focused on treatment of uterine fibroids and related symptoms such as abnorma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asoprisnil (asoprisnil)

Snippet

Sponsor: Abbott | Conditions: Fibroid Uterus, Leiomyoma | Phase 3 | Status: COMPLETED